BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 32709383)

  • 1. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency.
    Grynberg M; Jacquesson L; Sifer C
    Fertil Steril; 2020 Oct; 114(4):848-853. PubMed ID: 32709383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First birth achieved after in vitro maturation of oocytes from a woman endowed with multiple antral follicles unresponsive to follicle-stimulating hormone.
    Grynberg M; Peltoketo H; Christin-Maître S; Poulain M; Bouchard P; Fanchin R
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4493-8. PubMed ID: 23956344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful live birth after
    Chansel-Debordeaux L; Rault E; Depuydt C; Soula V; Hocké C; Jimenez C; Creux H; Papaxanthos-Roche A
    Gynecol Endocrinol; 2021 Dec; 37(12):1138-1142. PubMed ID: 34008458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The live birth in a woman with resistant ovary syndrome after in vitro oocyte maturation and preimplantation genetic testing for aneuploidy.
    Kornilov NV; Pavlova MN; Yakovlev PP
    J Assist Reprod Genet; 2021 Jun; 38(6):1303-1309. PubMed ID: 33495936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma.
    Bry-Gauillard H; Belin F; Vinolas C; Renoult-Pierre P; Massin N; Young J; Sifer C; Grynberg M
    Reprod Biomed Online; 2022 Feb; 44(2):304-309. PubMed ID: 34815159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
    Gayete-Lafuente S; Turan V; Oktay KH
    J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
    Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
    J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
    Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
    Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
    Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.
    Matsumoto K; Imakawa K; Hayashi C
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):312. PubMed ID: 28931393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
    Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
    Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes.
    Li Y; Pan P; Yuan P; Qiu Q; Yang D
    J Ovarian Res; 2016 Sep; 9(1):54. PubMed ID: 27599836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
    Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
    Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
    Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
    Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
    Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
    Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.